Literature DB >> 32308001

Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.

Birkir Reynisson1, Carolina Barra1, Saghar Kaabinejadian2, William H Hildebrand3, Bjoern Peters4,5, Morten Nielsen1,6.   

Abstract

Major histocompatibility complex II (MHC II) molecules play a vital role in the onset and control of cellular immunity. In a highly selective process, MHC II presents peptides derived from exogenous antigens on the surface of antigen-presenting cells for T cell scrutiny. Understanding the rules defining this presentation holds critical insights into the regulation and potential manipulation of the cellular immune system. Here, we apply the NNAlign_MA machine learning framework to analyze and integrate large-scale eluted MHC II ligand mass spectrometry (MS) data sets to advance prediction of CD4+ epitopes. NNAlign_MA allows integration of mixed data types, handling ligands with multiple potential allele annotations, encoding of ligand context, leveraging information between data sets, and has pan-specific power allowing accurate predictions outside the set of molecules included in the training data. Applying this framework, we identified accurate binding motifs of more than 50 MHC class II molecules described by MS data, particularly expanding coverage for DP and DQ beyond that obtained using current MS motif deconvolution techniques. Furthermore, in large-scale benchmarking, the final model termed NetMHCIIpan-4.0 demonstrated improved performance beyond current state-of-the-art predictors for ligand and CD4+ T cell epitope prediction. These results suggest that NNAlign_MA and NetMHCIIpan-4.0 are powerful tools for analysis of immunopeptidome MS data, prediction of T cell epitopes, and development of personalized immunotherapies.

Entities:  

Keywords:  MHC II; antigen presentation; bioinformatics; immunoinformatics; immunology; immunopeptidomics; machine learning; mass spectrometry; neoepitopes

Mesh:

Substances:

Year:  2020        PMID: 32308001     DOI: 10.1021/acs.jproteome.9b00874

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  71 in total

1.  Landscape of helper and regulatory antitumour CD4+ T cells in melanoma.

Authors:  Giacomo Oliveira; Kari Stromhaug; Nicoletta Cieri; J Bryan Iorgulescu; Susan Klaeger; Jacquelyn O Wolff; Suzanna Rachimi; Vipheaviny Chea; Kate Krause; Samuel S Freeman; Wandi Zhang; Shuqiang Li; David A Braun; Donna Neuberg; Steven A Carr; Kenneth J Livak; Dennie T Frederick; Edward F Fritsch; Megan Wind-Rotolo; Nir Hacohen; Moshe Sade-Feldman; Charles H Yoon; Derin B Keskin; Patrick A Ott; Scott J Rodig; Genevieve M Boland; Catherine J Wu
Journal:  Nature       Date:  2022-05-04       Impact factor: 49.962

Review 2.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

Review 3.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

4.  Integral Use of Immunopeptidomics and Immunoinformatics for the Characterization of Antigen Presentation and Rational Identification of BoLA-DR-Presented Peptides and Epitopes.

Authors:  Andressa Fisch; Birkir Reynisson; Lindert Benedictus; Annalisa Nicastri; Deepali Vasoya; Ivan Morrison; Søren Buus; Beatriz Rossetti Ferreira; Isabel Kinney Ferreira de Miranda Santos; Nicola Ternette; Tim Connelley; Morten Nielsen
Journal:  J Immunol       Date:  2021-03-31       Impact factor: 5.422

5.  Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis.

Authors:  Sergio Muñiz-Castrillo; Julien Jacques Hedou; Aditya Ambati; David Jones; Alberto Vogrig; Anne-Laurie Pinto; Marie Benaiteau; Thomas de Broucker; Laura Fechtenbaum; Pierre Labauge; Matthew Murnane; Claire Nocon; Irina Taifas; Clément Vialatte de Pémille; Dimitri Psimaras; Bastien Joubert; Valérie Dubois; Valentin Wucher; Virginie Desestret; Emmanuel Mignot; Jérôme Honnorat
Journal:  Brain       Date:  2021-10-22       Impact factor: 13.501

6.  Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.

Authors:  Mark N Lee; Matthew Meyerson
Journal:  Sci Immunol       Date:  2021-01-22

7.  Improved prediction of HLA antigen presentation hotspots: Applications for immunogenicity risk assessment of therapeutic proteins.

Authors:  Anders Steenholdt Attermann; Carolina Barra; Birkir Reynisson; Heidi Schiøler Schultz; Ulrike Leurs; Kasper Lamberth; Morten Nielsen
Journal:  Immunology       Date:  2020-10-19       Impact factor: 7.397

8.  Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA).

Authors:  Rongzeng Liu; Wei Jiang; Elizabeth D Mellins
Journal:  Cell Mol Immunol       Date:  2021-06-11       Impact factor: 11.530

9.  A novel 2 bp deletion variant in Ovine-DRB1 gene is associated with increased Visna/maedi susceptibility in Turkish sheep.

Authors:  Yalçın Yaman; Veysel Bay; Ramazan Aymaz; Murat Keleş; Yasemin Öner; Eden Yitna Teferedegn; Cemal Ün
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

10.  Landscape and selection of vaccine epitopes in SARS-CoV-2.

Authors:  Christof C Smith; Kelly S Olsen; Benjamin G Vincent; Alex Rubinsteyn; Kaylee M Gentry; Maria Sambade; Wolfgang Beck; Jason Garness; Sarah Entwistle; Caryn Willis; Steven Vensko; Allison Woods; Misha Fini; Brandon Carpenter; Eric Routh; Julia Kodysh; Timothy O'Donnell; Carsten Haber; Kirsten Heiss; Volker Stadler; Erik Garrison; Adam M Sandor; Jenny P Y Ting; Jared Weiss; Krzysztof Krajewski; Oliver C Grant; Robert J Woods; Mark Heise
Journal:  Genome Med       Date:  2021-06-14       Impact factor: 15.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.